Although it is not yet clear how FGFR2 gain-of function variants impact the mechanism for AF closure we described here, our study indicates that suture-specific requirements for FGF and/or WNT signaling levels could be the key to answering these questions. The gene discussed is FGFR2; the disease is atrial fibrillation.